MindBody raising $270 million through securities offering
Story updated at 3 p.m. June 8: Wellness-oriented software firm MindBody announced new details in its plans to raise capital through a debt securities offering for private investors June 8. The San Luis Obispo-based company raised its goal from $200 million to $270 million in convertible senior notes, which will come due in 2023. Net Read More →
Read More →
Simi Valley’s AeroVironment sells energy segment to Webasto
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →FDA approves biosimilar of Amgen’s Neulasta
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →State sues Plains All American Pipeline over lost revenue
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Latina rises to the top at Oxnard aerospace manufacturing firm
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Solar technology firm cleans up at UCSB New Venture Competition
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →FDA decides not to approve Amgen biosimilar, at least for now
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Home of the Week
Sponsored Listing
Elegant & Spacious Italian-Styled Home, Goleta
